STEPHANIE STOVALL: Open Payments
NPI 1386670420 · DELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$814 in 37 payments from 13 companies in 2025. Trend: 2023 $1,053 · 2024 $965 · 2025 $814
Food & beverage: $814
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $160 |
| Novo Nordisk Inc | 7 | $152 |
| ABBVIE INC. | 5 | $136 |
| PFIZER INC. | 3 | $65 |
| Amgen Inc. | 3 | $58 |
| Lilly USA, LLC | 3 | $52 |
| Phathom Pharmaceuticals, Inc. | 1 | $47 |
| Exact Sciences Corporation | 2 | $40 |
| Medtronic, Inc. | 1 | $29 |
| Abbott Laboratories | 1 | $22 |
Products named: UBRELVY, AIRSUPRA, Rybelsus, ELIQUIS, FARXIGA, MOUNJARO, Wegovy, VOQUEZNA.
Industry payments across FL — which companies pay providers there.
